While there is currently no standard therapy in the literature for multiple primary cancers, it is the authors’ suggestion that targeted therapies may be a promising choice for these cases
📌 3 Key Takeaways
🎯
Objective & Hypothesis:While multiple primary tumors are rarely reported in literature, we expect that it will be seen more often in the future as a result of improvements in diagnosis and treatment of cancer.
📊
Key Findings & Data:Presently described is oncological response for a 70-year-old women with multiple primary cancers - breast and lung - in which 2 targeted therapies were administered.
💡
Conclusion & Impact:While there is currently no standard therapy in the literature for multiple primary cancers, it is the authors’ suggestion that targeted therapies may be a promising choice for these cases
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
While multiple primary tumors are rarely reported in literature, we expect that it will be seen more often in the future as a result of improvements in diagnosis and treatment of cancer. Molecular targeted therapies are promising modalities that are now used more commonly. Presently described is oncological response for a 70-year-old women with multiple primary cancers - breast and lung - in which 2 targeted therapies were administered. While there is currently no standard therapy in the literature for multiple primary cancers, it is the authors’ suggestion that targeted therapies may be a promising choice for these cases
🔖
Cite This Article
NAMAL, E., GÖKMEN, E., CERCİZ, Ö. P. (2022). Medical Treatment with Two Targeted Therapies for an Oncology Patient with Double Primary Cancer: Case Report. Türk Onkoloji Dergisi, Cilt: 31 - Sayı: 2, 27–29. https://ajindex.com/articles/639301
Warren S, Gates O. Multiple primary malignant tumors: A survey of the literature and a statistical study. Am J Cancer 1932;16:1358–414
Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 2007;12(1):20–37
Liu FS, Qin DX, Wang QL. The clinical pathology analysis of 172 cases of multiple primary malignant tumors. Chin J Oncol 1979;1(2):113
Babacan NA, Aksoy S, Cetin B, Ozdemir NY, Benekli M, Uyeturk U, et al. Multiple primary malignant neoplasms: multi-center results from Turkey. J BUON 2012;17(4):770–5
Frödin JE, Ericsson J, Barlow L. Multiple primary malignant tumors in a national cancer registry-reliability of reporting. Acta Oncol 1997;36(5):465–9
Macdonald EJ. Occurrence of multiple primary cancers in a population of 200,000. Acta Unio Int Contra Cancrum 1960;16:1702–10
Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 2007;99(21):1634–43.